The effects of electroconvulsive therapy on melatonin

Area of Science:

• Neuroscience
• Psychiatry
• Endocrinology

Background:

• Antidepressant medications' effects on melatonin are documented.
• No studies have investigated electroconvulsive therapy's (ECT) impact on melatonin.
• Melatonin plays a role in circadian rhythms and mood regulation.

Purpose of the Study:

• To investigate the effect of electroconvulsive therapy (ECT) on melatonin production.
• To explore the relationship between ECT's therapeutic response and melatonin levels.

Main Methods:

• Measured 6-sulfatoxymelatonin (6MT), melatonin's major urinary metabolite, before and after ECT.
• Utilized enzyme-linked immunosorbent assay (ELISA) for 6MT quantification in 24-hour urine samples.
• Assessed depression severity using the Hamilton Rating Scale for Depression.

Main Results:

• Significant improvement in Hamilton Rating Scale for Depression scores (p < 0.0001).
• Significant decrease in 24-hour 6MT excretion post-ECT (p < 0.016).
• Significant reduction in daytime 6MT excretion observed (p < 0.008).

Conclusions:

• ECT treatment is associated with a decrease in endogenous melatonin production.
• A therapeutic response to ECT correlates with reduced melatonin levels.
• Further research is warranted to elucidate the mechanisms underlying this association.